Colorectal cancer (CRC) is a leading cause of death worldwide, despite progress made in
detection and management through surgery, chemotherapy, radiotherapy, and …

The high incidence of rectal cancer in both sexes makes it one of the most common tumors,
with significant morbidity and mortality rates. To define the best treatment option and …

Background: Liver metastases are a leading cause of cancer-associated deaths in patients
affected by colorectal cancer (CRC). The multidisciplinary strategy to treat CRC is more …

Importance Rectal cancer management has significantly evolved over the last 2 decades.
Objective This study aimed to evaluate trends in the characteristics, treatment, and outcomes …

Adoptive T lymphocyte (T cell) transfer and tumour‐specific peptide vaccines are innovative
cancer therapies. An accurate assessment of the specific reactivity of T cell receptors (TCRs) …

Background Radiotherapy resistance is the main cause of low tumor regression for locally
advanced rectum adenocarcinoma (READ). The biomarkers correlated to radiotherapy …

Adjuvant chemotherapy following surgical intervention remains the primary treatment option
for patients with localized colorectal cancer (CRC). However, a significant proportion of …

Abstract Background Flow Cytometry is an analytical technique for the precise quantification
of cellular phenotype. Intraoperative Flow Cytometry (iFC) utilizes flow cytometry for DNA …

Background The early-onset rectal cancer with rapidly increasing incidence is considered to
have distinct clinicopathological and molecular profiles with high-risk features. This leads to …

There has been a staggering increase in the incidence of rectal cancer, drawing our
attention to early detection and optimization of its medical and surgical treatment. With this …